Patient Leaflet Updated 07-Nov-2023 | Chiesi Limited
Bramitob Nebuliser Solution
Bramitob 300mg/4ml Nebuliser Solution
Tobramycin
1. What Bramitob is and what it is used for
2. What you need to know before you use Bramitob
3. How to use Bramitob
4. Possible side effects
5. How to store Bramitob
6. Contents of the pack and other information
Bramitob contains tobramycin which is an antibiotic belonging to a family called the aminoglycosides. It fights infections caused by Pseudomonas aeruginosa.
Bramitob is used for treating chronic chest infections in patients with cystic fibrosis caused by Pseudomonas bacteria. It kills the bacteria and helps to improve your breathing. Pseudomonas is a very common bacterium that infects nearly all patients with cystic fibrosis at some time during their lives. Some people do not get this infection until later on in their lives while others get it very young. If infection is not properly controlled it will continue to damage the lungs causing further problems. As Bramitob is breathed-in the antibiotic, tobramycin, can get straight into your lungs to work against the bacteria causing the infection.
Bramitob is indicated only for patients aged 6 years and older.
To achieve the best results please make every effort to use your medicine as instructed.
Talk to your doctor or pharmacist before using Bramitob.
The tobramycin in Bramitob is one of a group of medicines that can occasionally cause hearing loss, dizziness and kidney damage (see also Section 4 on the back of the leaflet, Possible side effects). It is important that you tell your doctor if any of the following applies to you:
Your doctor may test your hearing before starting Bramitob or at any time during your Bramitob treatment.
Before starting treatment, please tell your doctor or pharmacist if you are taking or have recently taken or might take any other medicines, including medicines obtained without a prescription.
You may be receiving injections of tobramycin or other aminoglycosides as well as inhaling Bramitob. Such injections, which may increase the very low body levels of aminoglycoside caused by inhaling Bramitob, should be avoided when the following medicines are being taken:
If this applies to you, you should speak to your doctor.
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
It is not known whether inhaling this medicine while you are pregnant causes side effects.
When they are given by injection, tobramycin and other aminoglycoside antibiotics can cause harm to an unborn child, such as deafness and kidney problems.
If you are breast feeding, you should talk to your doctor before using this medicine.
Bramitob has minor influence on the ability to drive and use machines.
In rare cases Bramitob may make you feel dizzy. It is therefore possible that Bramitob could affect your ability to drive a car or operate machinery.
Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. Instructions for using Bramitob are given after the dosage section.
Do not mix or dilute your Bramitob with any other medicine in your nebuliser.
If you are taking several different treatments for cystic fibrosis you should take them in the following order:
Also check the order with your doctor.
Bramitob should be used with a clean, dry PARI LC PLUS or PARI LC SPRINT reusable nebuliser (for your own personal use only) and a suitable compressor. Ask your doctor or physiotherapist for advice on which compressor to use.)
The single-dose Bramitob container should be opened just before use. Any unused solution that is not immediately used should be discarded.
If you inhale too much Bramitob you may get a very hoarse voice. Make sure you tell your doctor as soon as possible.
Then continue with your next dose as normal.
Bramitob is intended for use in a nebuliser, do not use it in any other way.
1. Wash your hands thoroughly with soap and water before opening your single-dose container according to the following instructions.
2. Bend the single-dose container backwards and forwards (Figure A).
3. Carefully separate a new container from the strip, firstly from the top, then in the middle (Figure B), leaving the rest in the foil envelope.
4. Open the single-dose container by rotating the flap as indicated by the arrow (Figure C).
5. Gently squeeze the contents of the container into the nebuliser chamber (Figure D).
6. Turn on the compressor.
7. Check if there is a steady mist coming from the mouthpiece.
8. Sit or stand in an upright position so that you can breathe normally.
9. Place the mouthpiece between your teeth and on top of your tongue. Breathe normally, but only through your mouth (you may find noseclips helpful). Try not to block the end of the mouthpiece with your tongue.
10. Continue until all the Bramitob is used up, this should take about 15 minutes.
11. If you are interrupted, or need to cough or rest during your treatment, turn off the compressor to save your medicine. Turn the compressor on again when you are ready to restart your treatment.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Looking after your nebuliser and compressor:
Please follow the manufacturer’s instructions for the care and use of your nebuliser and compressor.
Like all medicines, Bramitob can cause side effects, although not everybody gets them.
If you are not sure what the side effects below are, ask your doctor to explain them to you.
The most common side effects of Bramitob which may affect more than 1 in 100 people are: Cough and hoarseness.
Uncommon side effects of Bramitob which may affect more than 1 in 1,000 people are: thrush in the mouth (candida infection), vertigo, loss of hearing, increased saliva quantities, inflammation of the tongue, rash, sore throat, hepatic enzymes increased in the blood, noisy breathing, nausea, mucosal dry, coughing up blood, pain in the throat (oropharyngitis) or chest, loss of hearing, headache, shortness of breath, weakness, producing more sputum (the substance you cough up) than normal, gastric pain and fungal infection.
Rare side effects which may affect more than 1 in 10,000 people are: loss of appetite, ringing in the ears, chest tightness or difficulty breathing, loss of voice, nose bleeds, runny nose, mouth ulcers, vomiting, taste disturbances, asthma, dizziness, loss of strength, fever, pain, laryngitis (voice alteration with sore throat and difficulty swallowing).
Very Rare side effects which may affect less than 1 in 10,000 people are: swelling of lymph glands, drowsiness, ear problems, ear pain, hyperventilation, sinusitis, diarrhoea, allergic reactions including urticaria and pruritus, deficiency of available oxygen in the blood and bodily tissues (hypoxia), back pain, abdominal pain and generally feeling unwell.
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Reporting of side effects
If you get any side effects talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via:
United Kingdom:
or search for MHRA Yellow Card in the Google Play or Apple App Store
Ireland:
By reporting side effects you can help provide more information on the safety of this medicine.
The active substance is tobramycin. Each 4ml single-dose container contains tobramycin 300 mg.
The other ingredients are sodium chloride, sulphuric acid and sodium hydroxide (for pH adjustment), water for injections.
Bramitob appears as a clear, yellowish solution.
Your Bramitob Nebuliser Solution comes in 4ml single-dose containers. There are 4 containers in each sealed bag, in box sizes of 4, 16, 28 or 56.
Not all pack sizes may be marketed.
Marketing Authorisation Holder:
UK:
Ireland:
Manufacturer:
or
This medicinal product is authorised in the Member States of the EEA under the following names:
Austria: Bramitob Netherlands: Bramitob
Czech Republic: Bramitob Norway: Bramitob
Denmark: Bramitob Poland: Bramitob
Finland: Bramitob Portugal: Bramitob
Germany: Bramitob Slovak Republic: Bramitob
Greece: Bramitob Spain: Bramitob
Hungary: Bramitob Sweden: Bramitob
Ireland: Bramitob United Kingdom (Northern Ireland & Great Britain): Bramitob
Italy: Tobrineb
Is this leaflet hard to see or read? Phone for help: 0161 488 5555 (from UK)
+44161 488 5555 (from Ireland)
This leaflet was last revised in 11/2023
CP0005/13
Chiesi Limited, 333 Styal Road, Manchester, M22 5LG
0800 009 2329
http://www.chiesi.uk.com
https://www.chiesimedical.co.uk
+44 (0) 161 488 5555
www.chiesi.uk.com/supply-of-chiesi-products
+44 (0)1748 827 271